Revanesse Ultra™+

Revanesse Ultra+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, intended for the treatment of facial rhytides and lipoatrophy. Practitioners inject it into the skin, and its implantation life averages between 6 and 12 months. The product contains 25 mg/mL of BDDE cross-linked hyaluronic acid with 0.3% lidocaine in phosphate-buffered saline and is intended for professional use. Each box includes two 1.2 mL syringes and up to two sterilised 27G needles.

• Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
• Indicated for facial rhytides and for lipoatrophy
• Injected into the skin, with the plane chosen by the practitioner
• Implantation life averages 6 to 12 months
• Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
• BDDE cross-linked in phosphate-buffered saline
• CE marked 0653 for the syringe, with CE 0123 needles

Wskazania i zastosowanie profesjonalne

Główne wskazania

• Facial rhytides
• Lipoatrophy

Zastosowanie profesjonalne

For professional use. Revanesse Ultra+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Obszary zabiegowe

• Face

Profil pacjenta

For adult patients seeking treatment of facial rhytides or lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Jak działa Revanesse Ultra™+ ​

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty REVANESSE od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania